High-Throughput Recombinant Antibody Production

Accelerating Recombinant Antibody Production: A Robust and Seamless, End-to-End Workflow Solution

Recombinant antibody production is essential for therapeutic antibody development, biologics research, and high-throughput discovery workflows. However, achieving consistently high antibody yields while managing large panels of candidates remains a major challenge.

This application note introduces a robust, scalable, end-to-end antibody expression and screening workflow designed to process hundreds to thousands of recombinant antibody expression constructs. By integrating optimized vector backbones, advanced expression systems, and streamlined screening methods, this platform significantly improves efficiency, reduces cost, and delivers higher-quality recombinant antibodies for downstream characterization and development.

What You'll Learn

• How optimized antibody vector backbones improve expression efficiency and boost recombinant antibody yields
• Comparative performance data demonstrating significantly higher antibody expression in HEK293 and CHO cell lines using optimized vectors versus commercial alternatives
• Successful expression of difficult or low-producing antibody sequences, including customer-provided constructs that typically challenge standard platforms